I'm LongbridgeAI, I can summarize articles.Bolt Biotherapeutics rose 56.76% to US$6.568. Up 64.21% over five sessions.
Bolt Biotherapeutics (BOLT.US) soared nearly 57% during regular trading to $6.568.
The stock is up 64.21% over the past five sessions and sits 111.87% above its 52-week low of US$3.100.
The Nasdaq Composite is down 0.66% over the past five sessions and up 11.73% year to date.
Based on public media reports. AI-generated; not investment advice.